Skip to content
10-Q

Quarterly Report

VAPORIN, INC.

0001493152-14-003622

← back to feed
Filed
Nov 12, 2014 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow Q3 2014 · Sep 30, 2014 −$2.82M
Operating Cash Flow restated Q3 2014 · Sep 30, 2013 −$515.24K
Sga Expense Q3 2014 · Sep 30, 2014 $3.45M
Sga Expense restated Q3 2014 · Sep 30, 2013 $148.86K
Net Income Q3 2014 · Sep 30, 2014 −$3.94M
Net Income restated Q3 2014 · Sep 30, 2013 −$161.39K
Operating Income Q3 2014 · Sep 30, 2014 −$3.62M
Operating Income restated Q3 2014 · Sep 30, 2013 −$161.39K
Gross Profit Q3 2014 · Sep 30, 2014 $661.34K
Gross Profit Q3 2014 · Sep 30, 2013 −$12.53K
Cost Of Revenue Q3 2014 · Sep 30, 2014 $778.03K
Cost Of Revenue Q3 2014 · Sep 30, 2013 $40.99K
Revenue Q3 2014 · Sep 30, 2014 $1.44M
Revenue Q3 2014 · Sep 30, 2013 $28.46K